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ABSTRACT
Invariant natural killer T (iNKT) cells are innate T cells restricted by CD1d molecules. They 
are positively selected in the thymic cortex and migrate to the medullary area, in which they 
differentiate into 3 different lineages. Promyelocytic leukemia zinc finger (PLZF) modulates 
this process, and PLZFhigh, PLZFintermediate, and PLZFlow iNKT cells are designated as NKT2, 
NKT17, and NKT1 cells, respectively. Analogous to conventional helper CD4 T cells, each 
subset expresses distinct combinations of transcription factors and produces different 
cytokines. In lymphoid organs, iNKT subsets have unique localizations, which determine 
their cytokine responses upon antigenic challenge. The lineage differentiation programs 
of iNKT cells are differentially regulated in various mice strains in a cell-intrinsic manner, 
and BALB/c mice contain a high frequency of NKT2 cells. In the thymic medulla, steady 
state IL-4 from NKT2 cells directly conditions CD8 T cells to become memory-like cells 
expressing Eomesodermin, which function as premade memory effectors. The genetic 
signature of iNKT cells is more similar to that of γδ T cells and innate lymphoid cells (ILCs) 
than of conventional helper T cells, suggesting that ILCs and innate T cells share common 
developmental programs.
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INTRODUCTION
Innate or unconventional T cells develop in the thymus but are phenotypically distinct from 
conventional T cells. Invariant natural killer T (iNKT), γδ T, mucosal-associated invariant T 
(MAIT), and major histocompatibility complex (MHC) class Ib-reactive T cells belong to this 
category (1,2). Among them, iNKT cells are γδ T cells derived from double positive cortical 
thymocytes (3) and are selected by thymocytes presenting lipid antigens in the context of 
CD1d molecules (4), whereas conventional CD4 and CD8 T lymphocytes are selected by 
peptide antigens presented by MHC class Ia and class II molecules. NKT cells develop as 
memory cells in the thymus, and promyelocytic leukemia zinc finger (PLZF) regulates their 
development and effector differentiation (5,6).
There are 3 functional subsets of iNKT cells in the thymus, which produce distinct 
combination of cytokines and lineage-specific transcription factors. These subsets are 
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designated as NKT1, NKT2, and NKT17, and they respectively express T-box 21 (T-bet), 
GATA binding protein-3 (GATA3), and retinoic acid receptor-related orphan nuclear receptor 
gamma (RORγt) to produce interferon-γ (IFN-γ), IL-4, and IL-17. NKT2 cells produce 
copious amounts of IL-4 at steady state, which elicits various systemic effects through the 
phosphorylation of signal transducer and activator of transcription 6 (STAT6) (7). IL-4 
directly conditions CD8 T cells to become memory-like cells in the thymus, stimulates B 
cells to make IgE, and induces dendritic cells to secrete T helper (Th) 2-type chemokines 
like chemokine (C-C motif ) ligand (CCL) 17 and CCL22. The development of iNKT cells 
is differentially regulated amongst various mouse strains, and BALB/c mice contain 
a high frequency of the IL-4-producing iNKT subset. In lymphoid organs, each iNKT 
subset displayed unique anatomic localization, which determined their responsiveness to 
intravenous or oral antigenic challenges (8). RNAseq analysis showed each iNKT subset has 
distinctive genetic signatures, and these features are more similar to γδ T cells and innate 
lymphoid cells (ILCs) than conventional T cells (9).
When iNKT cells are stimulated with α-galactosylceramide (αGalcer), they produce 
copious amounts of both Th1 and Th2 type cytokines and modulate immunity (10). In B16 
melanoma tumor models, they activate natural killer (NK) cells which eradicate tumor 
cells. In autoimmune disease models, activated NKT cells could suppress type I diabetes 
and experimental allergic encephalitis (11-13). In pneumococcal infection model, NKT cells 
recognized bacterial glycolipids and it was essential to control lung infection (14). Defective 
development of NKT cells were suggested to be a cause of type I diabetes in NOD mice and 
systemic lupus erythematosus in NZB×NZW F1 mice (15). As a prominent source of Th2 type 
cytokines, however, NKT cells aggravated allergic lug inflammation and induced oxazolone 
induced colitis (16,17). By secreting IFN-γ and IL-4, NKT cells suppressed transforming 
growth factor β1 (TGF-β1) production and worsened antibody induced joint inflammation 
(18). These extreme variety of immunological function of NKT cells at the steady state 
and upon activation, however, were not fully explained by previous model of NKT cell 
development and this review will describe recent advances of our knowledge about their 
ontogeny and effector differentiation.
IL-4 AND MEMORY-LIKE CD8 T CELLS
Bone marrow transplantation from wild type (WT) mice to β2m−/− mice resulted in the 
development of CD8 T cells with unique features (19). They were positively selected by donor 
hematopoietic cells, and restricted by unconventional MHC Ib molecules. In the thymus, these 
cells displayed the CD44high CD24low memory phenotype without cognate antigenic challenge 
and, as a preformed memory population, rapidly responded to Listeria monocytogenes in the 
periphery in H2-M3 dependent manner. Due to these properties, they were called innate 
(born as memory cells) or unconventional (restricted by MHC Ib) T cells. Similar phenotypes 
were observed in IL-2 inducible T cell kinase (ITK)−/−, and cAMP responsive element binding 
protein binding protein (CBP)−/− mice, in which the majority of CD8 single positive thymocytes 
displayed the CD44high CD24low memory phenotype in the thymus (20-22). However, unlike 
innate CD8 T cells they were restricted by conventional MHC Ia molecules expressed on 
cortical epithelial cells and recognized peptide antigens. As ITK and CBP are involved in T 
cell receptor (TCR) signaling, it was initially thought that altered TCR signaling strength 
redirected the fate of conventional T cells to innate lineages (23). However, later this was 
found not to be CD8 T cell-intrinsic, but was solely mediated by IL-4 cytokine secreted from 
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PLZFhigh CD4 T cells, which expanded in the absence of ITK, CBP or Krüppel-like factor 2 
(KLF2), as illustrated in Fig. 1 (24-27). Unlike conventional memory CD8 T cells, IL-4 induced 
memory CD8 T cells expressed only Eomes, but not T-bet, and Weinreich et al. (24) first used 
the term ‘memory-like CD8 T cells’ to describe this novel population. Eomes alone were 
sufficient to make rapid IFN-γ production from memory-like CD8 T cells upon stimulation. 
They were also positive for other memory surface markers including CD44, CD122, and 
CXCR3 and later NKG2d and CCL5 were identified to be unique markers of these cells (28). 
In various genetic alterations, PLZFhigh CD4 T cells were mainly αβ iNKT or γδ T cells and, 
so far, 13 different genotypes have been identified in B6 mice with Eomes-expressing CD8 
T cells expanded by this mechanism (Fig. 1) (27,29-31). Interestingly, compared to B6 mice, 
WT BALB/c mice had an approximately 10-fold higher number of PLZFhigh iNKT cells, and 
Eomes-expressing memory-like CD8 T cells (7). This was also true in fetal humans, in which 
PLZF-expressing innate CD4 T cells develop via thymocyte-thymocyte interactions generate 
Eomes-expressing memory CD8 T cells (32,33). These findings indicate it is an evolutionarily 
conserved mechanism in mice and humans that IL-4 secreted from expanded PLZFhigh CD4 T 
cells drives the development of Eomes-expressing memory-like CD8 T cells.
Subsequently, additional pathways generating Eomes-expressing CD8 T cells were revealed. 
In NFκB−/− and B-cell lymphoma/leukemia (Bcl11b) hypomorphic mice, they develop in a cell-
intrinsic manner, and in NEDD4 family-interacting protein 1 deficient (Ndfip1−/−) mice, these 
cells were only present in the periphery, but not in the thymus (27). In BALB/c Klf13−/− mice, the 
development of IL-4-producing iNKT cells was suppressed and Eomes+ CD8 T cells were not 
observed (34). In B6 mice, genetic deletion of various genes, including ubiquitously transcribed 
tetratricopeptide repeat, X chromosome (Utx), Jumonji Domain Containing 3, Histone Lysine 
Demethylase (Jmjd3), Histone Deacetylase 3 (Hdac3), and Transcription Factor E2α (E2a)/Helix-
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Figure 1. CD8 SP thymocytes become memory-like CD8+ T cells by IL-4 produced from PLZFhigh T cells. ETPs from bone marrow migrate to the thymus and 
differentiate into CD8 or CD4 SP thymocytes in the medulla. In WT BALB/c mice, IL-4 from iNKT cells conditions SP thymocytes to become memory-like cells 
expressing Eomes. CD4 SP thymocytes (dotted line) are much less efficient to become Eomes-positive memory-like cells compared to CD8 SP thymocytes (solid 
line). These features are also seen in genetically altered B6 mice (listed on the right side), in which PLZF-positive iNKT or γδ T cells expand. 
SP, single positive; ETP, early T cell progenitor; DP, double positive.
Loop-Helix Transcription Factor 4 (Heb) resulted in complete loss or decreased development of 
iNKT cells (35-37), but their phenotype was not tested in a BALB/c background.
Physiologically, IL-4 receptor expression on CD8 T cells was critical for the anti-malaria 
resistance of BALB/c mice (38,39) and developmental exposure of CD8 T cells to IL-4 
promoted Th1 responses during acute and chronic lymphocytic choriomeningitis virus 
(LCMV) infection (40,41). Therefore, memory-like CD8 T cells may be important for host 
defense against pathogenic invasions during the fetal and neonatal periods, when antigen-
specific memory T cells have not yet developed (42).
DEVELOPMENT OF INKT CELLS
The frequency of total iNKT cells was 3–5 times higher in BALB/c mice compared to B6 
mice, and BALB/c iNKT cells produced more IL-4 per cell (7). In the conventional model of 
iNKT cell development, or linear maturation model, CD24highCD44lowNK1.1− (stage 0) cells 
differentiate into CD24lowCD44lowNK1.1− cells (stage 1), which then upregulate CD44 (stage 2), 
and finally acquire NK1.1 (stage 3; Fig. 2A) (10). IL-4 is produced in stage 1 and 2 immature 
cells, and mature stage 3 cells produce IFN-γ. According to this model, it is likely that BALB/c 
368https://doi.org/10.4110/in.2017.17.6.365
Lineage Diversity of iNKT Cells
https://immunenetwork.org
Linear maturation model
MedullaCortexA
B
Stage 0 Stage 1
NKT2
NKT2
NKT0
PLZF
NKTp GATA3
NKT1
NKT1
PLZF
GATA3
BALB/c
B6
NKT2
NKT17
NKT17
IL-4 IFN-γ
IFN-γ
IL-4 IL-4
IL-4
IL-4
Stage 2 Stage 3
CD4+
CD8+
CD4+
CD8+
CD24hi
CD44lo
NK 1.1−
CD24hi
CD44lo
NK 1.1−
CD1d
lipid
PLZF
GATA3 RORγt
RORγt
TBET
TBET
Vα14
TCR
CD1d
lipid
Vα14
TCR
Lineage differentiation model
CD24lo
CD44lo
NK 1.1−
CD24lo
CD44hi
NK 1.1−
CD24lo
CD44hi
NK 1.1+
CD4+
IL17RB−
CD4/27+
IL17RB+
CD4/27−
IL17RB+/−
CD122+
IL17RB−
Figure 2. Comparison between the linear maturation and lineage differentiation models of iNKT cell development. Invariant TCR-expressing thymocytes are 
positively selected by CD1d+ cortical thymocytes. In the linear maturation model, NKT cells that produce IL-4 or IL-17 are considered immature, while mature 
cells produce IFN-γ. In the lineage differentiation model, undifferentiated PLZFhigh NKTp give rise to terminally differentiated NKT1, NKT2, and NKT17 cells.
iNKT cells remain immature and produce more IL-4. However, it was not possible to directly 
compare the development of iNKT cells between B6 and BALB/c mice, due to the absence 
of NK1.1 expression in the BALB/c strain. Instead, a transcription factor-based approach 
could distinguish between the 3 distinctive subsets of iNKT cells, which use a combination 
of transcription factors, including PLZF, T-bet, GATA3, and RORγt (Fig. 2B) (7,43). These 
cells are designated as NKT1, NKT2, and NKT17 cells analogous to conventional CD4 T cells. 
IL17RB is an IL25 receptor that defines the IL-4 producing capacity of iNKT cells (44) and 
PLZFhigh iNKT cells could be divided into IL17RB-positive NKT2 cells and IL17RB-negative 
natural killer T progenitor (NKTp) cells. NKT2 cells were GATA3- and IL17RB-positive and 
produced IL-4 at steady state, PLZFintermediate NKT17 cells were RORγt-positive and secreted 
IL-17 upon stimulation, and PLZFlow NKT1 cells were T-bet positive and secreted IFN-γ. In 
KN2 mice, which express human CD2 (huCD2) on the surface of IL-4 secreting cells (45), 
GATA-3 expression was highest in huCD2 positive NKT2 cells (unpublished data), NKTp and 
NKT17 cells expressed lower levels of GATA-3, and NKT1 cells, while also GATA-3 positive, 
had the lowest levels (Fig. 2B) (7). At steady state, only NKT2 cells produced IL-4. However, 
when activated with αGalcer, GATA3 and PLZF expression was upregulated in NKT1 cells, 
which could produce IFN-γ and IL-4 simultaneously (7). The molecular mechanism of 
these complex transcription factor expression patterns is not clear, but it appears that PLZF 
modulates these processes, as iNKT cells fail to differentiate in its absence (5,6). Compared 
to B6 mice, BALB/c mice had higher numbers of NKT2 and NKT17 cells, but the total 
numbers of NKT1 cells were not different, indicating that the development of NKT2 and 
NKT17 cells, but not NKT1 cells, are differentially regulated in BALB/c background (7).
According to the linear maturation model, IL-4 is produced from immature stage 1 or 2 cells, 
which are dependent on GATA3. However, this does not explain the normal development 
of stage 3 or NKT1 cells in GATA3-deficient mice (46). Alternatively, defective development 
of NKT1 or stage 3 cells in Tbx21−/− mice could facilitate the expansion of NKT2 and NKT17, 
corresponding to stage 1 or 2 cells (7,47). This is also unlikely to be explained by the lineage 
maturation model, as we generally do not expect progenitors to proliferate when their 
differentiation is blocked. Therefore, the conventional model of iNKT cell development fails 
to explain the phenotypes of iNKT cells in Tbx21 and Gata3 knockout mice. In the lineage 
differentiation model, terminally differentiated NKT1, NKT2, and NKT17 cells are derived 
from NKTp cells, and GATA3 is not required for their development (Fig. 2) (7). Therefore, 
GATA3-deficient iNKT cells preferentially differentiate into NKT1 cells, whereas T-bet deficient 
iNKT cells become NKT2 or NKT17 cells. This new model predicts that IL-4 producing NKT2 
cells are terminally differentiated and are not the precursors of NKT1 (stage 3) cells. This was 
proven in cell transfer assays using KN2 mice, in which huCD2−IL17RB−NKTp cells, but not 
huCD2+IL17RB+ NKT2 cells, gave rise to NKT1 cells (7) and NKT1 and NKT17 cells did not 
change their phenotypes (unpublished data). The reciprocal expansion of NKT2 and NKT1 
cells in Tbx21−/− and Gata3−/− mice, respectively (7,46) raises the question of whether the fates 
of individual cells are determined by TCR specificity at the progenitor level, or determined 
stochastically. A recent publication showed that a monoclonal iNKT TCR transgenic mouse had 
all 3 effector subsets of iNKT cells, indicating that the tissue microenvironment, rather than 
TCR specificity, plays a major role in lineage differentiation (48).
Amongst 6 different mice strains, 3 displayed Eomes-expressing memory CD8 T cells in the 
thymus, and their frequencies were proportional to the level of IL-4 produced from PLZFhigh 
NKT2 cells (7). Therefore, it appears that NKT2 cells are the primary determinants of IL-4 
levels in the mouse thymus.
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LOCALIZATION OF INKT CELLS
The CD1d tetramer is the gold standard biomarker for the detection of iNKT cells. However, 
the direct detection of iNKT cells using CD1d tetramers in fresh frozen or paraformaldehyde-
fixed tissue sections is not technically possible, as their binding affinity is much lower than 
antibodies and they require an intact TCR tertiary structure. Although previous studies have 
used the CD1d tetramer for immunohistochemistry, they did not validate the sensitivity of 
detection, leading to the preferential analysis of cells expressing high levels of CD1d tetramer 
(49,50) as NKT1 cells display lower TCR expression than NKT2 and NKT17 cells. A new 
method was employed to detect iNKT cells using CD1d tetramer staining, in which fresh 
thymi were incubated in PE-conjugated CD1d tetramer solution, then the CD1d tetramer 
signal was amplified using anti-PE antibody in fixed tissue sections (8). NKT1 and NKT17 
cells were further defined by T-bet and RORγt expression among CD1d tetramer-positive 
cells. The localization of all 3 subsets of iNKT cells was analyzed in lymphoid organs, and 
the results demonstrated that each subset has distinct anatomic localization. In the thymus, 
70% of NKT1 and NKT17 cells resided in the medulla, and 30% in the cortex. Ninety 
percent of IL-4 producing NKT2 cells were in the medullary area, and half of NKTp cells 
were estimated to be in the cortex (Fig. 3). Younger mice did not have a higher frequency of 
cortical iNKT cells, suggesting that cortical iNKT cells migrated from the medulla rather 
than being developed in the cortex. Overall, these findings suggest that NKTp cells migrate 
from the cortex to the medulla and differentiate into NKT1, NKT2, and NKT17 cells, and 
30% of NKT1 and NKT17 cells migrate back to the cortex (Fig. 3). It is not clear why and how 
NKT1 and NKT17 cells, but not NKT2 cells, migrate back to the cortex. It is unlikely that they 
move by passive overflow, as 99% of FOXP3-expressing regulatory T cells are found in the 
medullary area (8). Instead, NKT2 cells seem to be short lived, because NKT1 and NKT17 
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Figure 3. Schematic representation of iNKT cell development and localization in the thymus. Upon positive 
selection, NKTp cells move to the medullary area and undergo differentiation into various subsets. NKT2 cells 
produce IL-4 at steady state, which can condition medullary thymocytes to phosphorylate STAT6 and express 
Eomes. A portion of NKT1 and NKT17 cells migrate back to the cortical area. 
STAT6, signal transducer and activator of transcription 6.
cells are long-term components of the thymic populations of aged mice, while NKT2 cells 
gradually decrease, along with Eomes-expressing CD8 T cells (7). In the spleen, NKT1 cells 
are located in the red pulp and NKT2 cells are located in the T cell zone of the white pulp. 
In mesenteric lymph nodes, NKT2 cells are dominant and located in the T cell zone, while 
NKT1 cells are evenly distributed throughout the T and B cell areas. In other peripheral lymph 
nodes, NKT17 cells are enriched in the subcapsular area; consistent with a previous report 
that IL17-producing T cells reside there (51). The liver contains mostly NKT1 cells, with few 
NKT2 and NKT17 cells. These patterns determine the cytokine responses of iNKT cells 
upon administration of αGalcer, a potent stimulating ligand of iNKT cells. When αGalcer 
was intravenously injected, intravascular NKT1 cells in the splenic red pulp and liver were 
activated and produced IFN-γ and IL-4 simultaneously, which diffused systemically and 
affected other immune cells (8). Upon oral administration, αGalcer was delivered to the 
mesenteric lymph nodes, where it activated local resident NKT2 cells to produce IL-4 but not 
IFN-γ. In this case, IL-4 only activated neighboring lymphocytes, without systemic effects 
(8). Therefore, the tissue-specific distribution of iNKT subsets determines their cytokine 
responses, which might have potential applications in immune modification by localized 
conditioning of the cytokine milieu (8).
GENETIC SIGNATURE OF INKT CELLS
Affymetrix gene chip analysis of iNKT cells revealed that the transcriptional profile of iNKT 
cells is shared with NK and activated memory CD8 T cells, and partially overlaps with that of γδ 
T cells (52). However, this analysis used total splenic iNKT cells from B6 mice, in which NKT1 
cells predominate. To analyze the genetic signatures of NKT2 and NKT17 cells, iNKT subsets 
were isolated from BALB/c Tbx21GFP/KN2 dual reporter mice (9). Among CD1d tetramer-positive 
cells, NKT1 cells were sorted as Tbx21bright cells, and NKT17 cells were T-bet, CD4, and CD27 
triple-negative cells. NKT2 cells were T-bet−huCD2+IL17RB+CD4+CD27+ cells, and NKTp cells 
were defined as T-bet−huCD2−IL17RB−CD4+CD27+. As a result, NKTp, NKT1, NKT2, and NKT17 
cells all have distinct transcriptional natures, and clustering analysis revealed that NKT2 cells 
were transcriptionally more similar to NKT1 and NKT17 cells than NKTp cells, indicating that 
NKT2 and NKTp cells are distinct populations among PLZFhigh NKT cells. Pathway analysis 
showed that NKTp cells were enriched in genes involved in Myc signaling, and indeed, previous 
analysis of the iNKT phenotype in Myc-deficient mice showed that the development of iNKT 
cells was immediately arrested after stage 0 (53,54). Single cell-based RNA sequencing analysis 
further revealed that the functional iNKT cell subsets contain highly divergent subpopulations 
at the transcriptional and epigenomic levels (55).
Upon analysis of iNKT cells, the signature genes of each iNKT subset were compared with 
those of ILCs, γδ T cells, and conventional CD4 Th cells using public datasets (56-58). ILCs are 
composed of ILC1, ILC2, and ILC3 cells, which produce IFN-γ, IL-4, and IL-17, respectively, and 
previous analysis showed that ILC1 cells are indistinguishable from conventional NK cells at 
the transcriptional level (56). Interestingly, ILCs develop from cells that have expressed PLZF 
during their development (59), suggesting their potential transcriptional similarity with other 
PLZF-expressing T cells, including iNKT cells. Three molecularly distinct thymic γδ T cells 
were identified based on their TCR usage: V1 (Vγ1.1+Vδ6.3−), V6 (Vγ1.1+Vδ6.3+), and V2 (Vγ2+) 
cells, which produce IFN-γ, IL-4, and IL-17 respectively (58). V5 (Vγ5+) γδ T cells are rare in 
the thymus but enriched in the intestinal mucosa, and produce IFN-γ. A total of 14 different 
subsets, encompassing iNKT cells, ILCs, γδ T cells, and Th CD4 T cells, were analyzed at the 
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transcriptional level. However, the 4 datasets used different platforms to generate their raw 
data, and it was not possible to directly compare the genetic similarities among them. Instead, 
genes that were uniquely enriched in one of subsets in each cell type were compared by gene 
set enrichment analysis to obtain enrichment scores. It was found that the genetic signatures 
of iNKT subsets were most similar to those of γδ T cells, followed by ILCs. Th subsets had 
the least similarity, indicating that ILCs and innate T cells share similar genetics, which are 
distinguishable from conventional Th cells (9).
STRAIN SPECIFICITY
In the thymus, iNKT cells develop and differentiate into 3 distinct lineages from common 
progenitors. In BALB/c mice, NKT2 and NKT17 cells predominate, whereas NKT1 cells 
predominate in B6 mice. To address whether these differences are cell-intrinsic or -extrinsic, 
B6 or BALB/c fetal liver stem cells were transplanted into the fetal liver of the other strain 
(60). Donor cells established a stable hematopoietic mosaicism without inducing rejection 
or graft versus host disease. In this experiment, NKT1 cells predominated among B6-derived 
donor cells in the majority of BALB/c thymocytes, and NKT2 and NKT17 cells predominated 
among BALB/c derived donor cells in the majority of B6 thymocytes. These results 
demonstrate that the developmental differences in iNKT cells between B6 and BALB/c mice 
are cell-intrinsic rather than induced by external signals.
The frequencies of iNKT cells, especially NKT2 and NKT17 cells, were lower in adult bone 
marrow chimeras compared to WT mice (unpublished data), suggesting that, like γδ T cells, 
iNKT cells require the fetal thymic microenvironment for their development (61). Lin28b 
suppresses Let7 family microRNAs, and is highly expressed in fetal hematopoietic stem 
cells in mice and humans (62). Plzf contains regulatory motifs to bind Let7 (63) and Lin28b 
overexpression in retrogenic bone marrow chimeras promoted the development of NKT2 
and V6 (Vγ1.1+Vδ6.3+) γδ T cells, which expressed a high level of PLZF and produced IL-4 
(62). As Lin28b expression rapidly decreases in postnatal hematopoietic stem cells, it is 
likely that upregulation of Let7 family microRNAs, which are unrepressed by Lin28b after 
birth, favors the development of conventional lineage T cells. Consistent with this, we have 
observed that Lin28b expression is higher in the neonatal thymi of BALB/c mice compared to 
B6 mice (unpublished data), suggesting that Lin28b is a regulatory element driving NKT2 cell 
development in mice.
FUTURE PERSPECTIVES
In the periphery, iNKT cells differentiate into follicular helper NKT cells (NKTFH) and 
NKT10 cells, which secrete IL-21 and IL-10 respectively after αGalcer injection (64-66). 
At steady state, NKTFH cells were not present, and upon immunization with 4-hydroxy-3-
nitrophenylacetyl (NP)/αGalcer, NKTFH cells provided cognate help to B cells in a BCL6-
dependent manner. However, the effect was limited to IgM, and NKTFH cells did not enhance 
affinity maturation and long-lived plasma cell differentiation (64). NKT10 cells do not 
express PLZF and normally reside in fat tissue. Upon activation, NKT10 cells secrete IL-10, 
which can modulate regulatory T cells and M2 type macrophages, suggesting a potential 
role in controlling fat tissue metabolism and obesity (65). In disease models, NKT10 cells 
promote B16 melanoma growth and suppressed allergic encephalitis, indicating they are 
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an immunosuppressive subset (66). In summary, there are 5 different subtypes of iNKT 
cells including NKT1, NKT2, NKT17, NKTFH, and NKT10 cells in the thymus and periphery, 
analogous to conventional CD4 helper T cells. As iNKT cells are tissue resident and do not 
circulate (49), tissue-specific modulation of iNKT activation by localized delivery of αGalcer 
could be a potential modality to use iNKT cells for immunotherapeutic purposes.
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